IBDEI155 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19058,0)
 ;;=Z82.61^^94^917^21
 ;;^UTILITY(U,$J,358.3,19058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19058,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,19058,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,19058,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,19059,0)
 ;;=Z82.69^^94^917^44
 ;;^UTILITY(U,$J,358.3,19059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19059,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,19059,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,19059,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,19060,0)
 ;;=Z83.3^^94^917^28
 ;;^UTILITY(U,$J,358.3,19060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19060,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,19060,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,19060,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,19061,0)
 ;;=Z83.2^^94^917^24
 ;;^UTILITY(U,$J,358.3,19061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19061,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
 ;;^UTILITY(U,$J,358.3,19061,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,19061,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,19062,0)
 ;;=Z82.71^^94^917^47
 ;;^UTILITY(U,$J,358.3,19062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19062,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,19062,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,19062,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,19063,0)
 ;;=Z82.1^^94^917^23
 ;;^UTILITY(U,$J,358.3,19063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19063,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,19063,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,19063,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,19064,0)
 ;;=Z82.2^^94^917^27
 ;;^UTILITY(U,$J,358.3,19064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19064,1,3,0)
 ;;=3^Family Hx of Deafness/Hearing Loss
 ;;^UTILITY(U,$J,358.3,19064,1,4,0)
 ;;=4^Z82.2
 ;;^UTILITY(U,$J,358.3,19064,2)
 ;;=^5063366
 ;;^UTILITY(U,$J,358.3,19065,0)
 ;;=Z84.0^^94^917^48
 ;;^UTILITY(U,$J,358.3,19065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19065,1,3,0)
 ;;=3^Family Hx of Skin Diseases
 ;;^UTILITY(U,$J,358.3,19065,1,4,0)
 ;;=4^Z84.0
 ;;^UTILITY(U,$J,358.3,19065,2)
 ;;=^5063388
 ;;^UTILITY(U,$J,358.3,19066,0)
 ;;=Z82.79^^94^917^26
 ;;^UTILITY(U,$J,358.3,19066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19066,1,3,0)
 ;;=3^Family Hx of Congen Malform,Deformations & Chromsoml Abnlt
 ;;^UTILITY(U,$J,358.3,19066,1,4,0)
 ;;=4^Z82.79
 ;;^UTILITY(U,$J,358.3,19066,2)
 ;;=^5063374
 ;;^UTILITY(U,$J,358.3,19067,0)
 ;;=Z84.89^^94^917^46
 ;;^UTILITY(U,$J,358.3,19067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19067,1,3,0)
 ;;=3^Family Hx of Other Spec Conditions
 ;;^UTILITY(U,$J,358.3,19067,1,4,0)
 ;;=4^Z84.89
 ;;^UTILITY(U,$J,358.3,19067,2)
 ;;=^5063393
 ;;^UTILITY(U,$J,358.3,19068,0)
 ;;=Z81.1^^94^917^20
 ;;^UTILITY(U,$J,358.3,19068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19068,1,3,0)
 ;;=3^Family Hx of Alcohol Abuse/Dependence
 ;;^UTILITY(U,$J,358.3,19068,1,4,0)
 ;;=4^Z81.1
 ;;^UTILITY(U,$J,358.3,19068,2)
 ;;=^5063359
 ;;^UTILITY(U,$J,358.3,19069,0)
 ;;=Z82.62^^94^917^45
 ;;^UTILITY(U,$J,358.3,19069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19069,1,3,0)
 ;;=3^Family Hx of Osteoporosis
 ;;^UTILITY(U,$J,358.3,19069,1,4,0)
 ;;=4^Z82.62
 ;;^UTILITY(U,$J,358.3,19069,2)
 ;;=^5063372
 ;;^UTILITY(U,$J,358.3,19070,0)
 ;;=Z83.71^^94^917^25
 ;;^UTILITY(U,$J,358.3,19070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19070,1,3,0)
 ;;=3^Family Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,19070,1,4,0)
 ;;=4^Z83.71
 ;;^UTILITY(U,$J,358.3,19070,2)
 ;;=^5063386
